Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5 Million | 4.32 Million | 17.24 Million | 12.16 Million | 16.03 Million | 6.23 Million |
| Net Income | -14.25 Million | -12.82 Million | -1.96 Million | -7.77 Million | -12.64 Million | -2.72 Million |
| Depreciation & Amortization | 9.74 Million | 11.01 Million | 11.11 Million | 11.58 Million | 11.68 Million | 5.59 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.32 Million | 2.36 Million | 1.91 Million | 1.99 Million | 18.85 Million | 8.22 Million |
| Other non-cash items | 9.67 Million | 3.77 Million | 6.17 Million | 6.36 Million | -1.86 Million | -4.86 Million |
| Investing Cash Flow | -3.96 Million | -2 Million | -1.91 Million | -702 Thousand | -775 Thousand | -939 Thousand |
| Investments in PPE | -3.96 Million | -2 Million | -1.92 Million | -736 Thousand | -961 Thousand | -947 Thousand |
| Acquisitions | - | 2000.00 | 8000.00 | 34 Thousand | 186 Thousand | 8000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -6000.00 | -7000.00 | 10 Thousand | -73 Thousand | 8000.00 |
| Financing Cash Flow | 7.45 Million | -12.76 Million | -12.79 Million | -2.22 Million | -16.42 Million | -9.17 Million |
| Debt repayment | -13.58 Million | -224 Thousand | -182 Thousand | -44.4 Million | -2.09 Million | -1.81 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1000.00 | -12.53 Million | -12.61 Million | 42.17 Million | -14.33 Million | -7.35 Million |
| Accounts receivables | - | -8.42 Million | 56 Thousand | 9.37 Million | -65.3 Million | - |
| Accounts payables | 10.64 Million | 8.42 Million | -56 Thousand | 10.64 Million | 65.3 Million | - |
| Inventory | -8.94 Million | -6.35 Million | 672 Thousand | -9.17 Million | -47.71 Million | -26.33 Million |
| Other working capital | -11.97 Million | 8.71 Million | 1.24 Million | -8.85 Million | 66.56 Million | 34.55 Million |
| Cash at beginning of period | 2.06 Million | 12.49 Million | 9.95 Million | 721 Thousand | 1.89 Million | 5.77 Million |
| Cash at end of period | 551 Thousand | 2.06 Million | 12.49 Million | 9.95 Million | 721 Thousand | 1.89 Million |
| Capital Expenditure | -3.96 Million | -2 Million | -1.92 Million | -736 Thousand | -961 Thousand | -947 Thousand |
| Effect of forex changes on cash | - | - | - | -1000.00 | - | -1000.00 |
| Net cash flow / Change in cash | -1.51 Million | -10.43 Million | 2.53 Million | 9.23 Million | -1.17 Million | -3.87 Million |
| Free Cash Flow | -8.96 Million | 2.32 Million | 15.31 Million | 11.43 Million | 15.06 Million | 5.28 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.84 Million | -14.25 Million | -2.51 Million | -2.51 Million | -9.21 Million | -4.6 Million |
| Depreciation & Amortization | 4.9 Million | 9.74 Million | 2.57 Million | 2.57 Million | 4.59 Million | 2.29 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5.54 Million | -1.32 Million | -3.42 Million | -3.42 Million | 4.46 Million | -2.61 Million |
| Other non-cash items | 41 Thousand | 9.67 Million | 6.39 Million | 6.39 Million | -7.28 Million | 3.16 Million |
| Investing Cash Flow | -2.3 Million | -3.96 Million | -1.61 Million | -1.61 Million | -736 Thousand | -368 Thousand |
| Investments in PPE | -2.3 Million | -3.96 Million | -1.6 Million | -1.6 Million | -749 Thousand | -374.5 Thousand |
| Acquisitions | - | - | -13 Thousand | - | 13 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -6500.00 | -6500.00 | 6500.00 | 6500.00 |
| Financing Cash Flow | -3.3 Million | 7.45 Million | -3.27 Million | -3.27 Million | 9.88 Million | 3.23 Million |
| Debt repayment | -154 Thousand | -13.58 Million | -777 Thousand | - | -12.81 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.15 Million | 1000.00 | -3.27 Million | -3.27 Million | 3.23 Million | 3.23 Million |
| Accounts receivables | - | - | - | - | 2 Million | - |
| Accounts payables | 1.38 Million | 10.64 Million | 950 Thousand | - | 9.69 Million | - |
| Inventory | - | -8.94 Million | -2.46 Million | -2.46 Million | -2 Million | -2 Million |
| Other working capital | 4.16 Million | -11.97 Million | -959 Thousand | -959 Thousand | -5.23 Million | -611 Thousand |
| Cash at beginning of period | 551 Thousand | 2.06 Million | 4.28 Million | - | 2.06 Million | - |
| Cash at end of period | 3.59 Million | 551 Thousand | 551 Thousand | -1.86 Million | 4.28 Million | 1.1 Million |
| Capital Expenditure | -2.3 Million | -3.96 Million | -1.6 Million | -1.6 Million | -749 Thousand | -374.5 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.04 Million | -1.51 Million | -3.72 Million | -1.86 Million | 2.21 Million | 1.1 Million |
| Free Cash Flow | 6.34 Million | -8.96 Million | 1.41 Million | 1.41 Million | -7.67 Million | -2.13 Million |
ORRAF
HERMA
STLR
KCE-R
TIMA
DHRUV